5-102419902-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_173488.5(SLCO6A1):c.1396C>T(p.Leu466Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000275 in 1,456,496 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_173488.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLCO6A1 | NM_173488.5 | c.1396C>T | p.Leu466Phe | missense_variant | 8/14 | ENST00000506729.6 | NP_775759.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLCO6A1 | ENST00000506729.6 | c.1396C>T | p.Leu466Phe | missense_variant | 8/14 | 1 | NM_173488.5 | ENSP00000421339.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000123 AC: 3AN: 244670Hom.: 0 AF XY: 0.0000151 AC XY: 2AN XY: 132204
GnomAD4 exome AF: 0.00000275 AC: 4AN: 1456496Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 724350
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2024 | The c.1396C>T (p.L466F) alteration is located in exon 8 (coding exon 8) of the SLCO6A1 gene. This alteration results from a C to T substitution at nucleotide position 1396, causing the leucine (L) at amino acid position 466 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at